November saw the FDA grant its first emergency use approval for an at-home, self-collected nasal swab test for COVID-19 and approve the first drugs for some rare genetic diseases – including two that cause premature aging and death – among other approvals. Now, today’s article takes a look at the biotech companies awaiting FDA rulings in December. For more, CLICK HERE.
These Biotechs Are Awaiting FDA Rulings In December
- by Alex Clarke
